Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Deferred Taxes (2016 - 2018)

Historic Deferred Taxes for Niagen Bioscience (NAGE) over the last 8 years, with Q4 2018 value amounting to -$16000.0.

  • Niagen Bioscience's Deferred Taxes fell 10000.0% to -$16000.0 in Q4 2018 from the same period last year, while for Sep 2019 it was -$16000.0, marking a year-over-year decrease of 26000.0%. This contributed to the annual value of $2000.0 for FY2018, which is 9888.89% down from last year.
  • Latest data reveals that Niagen Bioscience reported Deferred Taxes of -$16000.0 as of Q4 2018, which was down 10000.0% from -$8000.0 recorded in Q3 2018.
  • Niagen Bioscience's 5-year Deferred Taxes high stood at $321037.0 for Q4 2016, and its period low was -$50000.0 during Q1 2018.
  • Its 3-year average for Deferred Taxes is $50227.5, with a median of -$8000.0 in 2017.
  • As far as peak fluctuations go, Niagen Bioscience's Deferred Taxes surged by 108137.44% in 2016, and later plummeted by 22500.0% in 2018.
  • Quarter analysis of 3 years shows Niagen Bioscience's Deferred Taxes stood at $321037.0 in 2016, then crashed by 102.49% to -$8000.0 in 2017, then plummeted by 100.0% to -$16000.0 in 2018.
  • Its last three reported values are -$16000.0 in Q4 2018, -$8000.0 for Q3 2018, and $76000.0 during Q2 2018.